Christopher I Wright

CIK 1838503 · View on SEC EDGAR ↗

Insider

First SEC filing: April 17, 2026 · Latest: June 12, 2026

On this page

Insider at

Insider transactions

0 buys (P) 1 sells (S) Net: $-90,200 + 39 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

39 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 12, 2026 ALKS S 10b5-1 2,000 $45.10 $90,200 25,680 Direct -7.23% Disposed 12.4% (price as of 2026-08-19)
Feb. 25, 2021 CYCN S 10b5-1 2,637 $3.99 $10,522 42,728 Direct -5.81% Disposed -94.8% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 8, 2025 ALKS Restricted Stock Unit Award Ordinary Shares (3,301) — — 3,301 Disposed
May 31, 2025 ALKS Restricted Stock Unit Award Ordinary Shares (8,013) — — 8,013 Disposed
May 21, 2025 ALKS Restricted Stock Unit Award Ordinary Shares (6,142) — — 6,142 Acquired
May 21, 2025 ALKS Non Qualified Stock Option (Right to Buy) Ordinary Shares (13,474) $30.53 May 21, 2035 13,474 Acquired
June 29, 2024 ALKS Restricted Stock Unit Award Ordinary Shares (6,104) — — 6,104 Disposed
June 8, 2024 ALKS Restricted Stock Unit Award Ordinary Shares (3,301) — — 3,301 Disposed
May 31, 2024 ALKS Non Qualified Stock Option (Right to Buy) Ordinary Shares (17,492) $23.40 May 31, 2034 17,492 Acquired
May 31, 2024 ALKS Restricted Stock Unit Award Ordinary Shares (8,013) — — 8,013 Acquired
Nov. 17, 2023 ALKS Restricted Stock Unit Award [F1] Ordinary Shares (119) — — 119 Acquired
Nov. 17, 2023 ALKS Non Qualified Stock Option (Right to Buy) [F1] Ordinary Shares (254) $30.72 June 29, 2033 254 Acquired
Nov. 17, 2023 ALKS Non Qualified Stock Option (Right to Buy) [F1] Ordinary Shares (231) $30.86 July 7, 2032 231 Acquired
Nov. 17, 2023 ALKS Restricted Stock Unit Award [F1] Ordinary Shares (129) — — 129 Acquired
Nov. 17, 2023 ALKS Non Qualified Stock Option (Right to Buy) [F1] Ordinary Shares (355) $28.40 June 8, 2032 355 Acquired
Nov. 17, 2023 ALKS Non Qualified Stock Option (Right to Buy) [F1] Ordinary Shares (14) $28.40 June 8, 2032 14 Acquired
July 7, 2023 ALKS Restricted Stock Unit Award Ordinary Shares (5,957) — — 5,957 Disposed
June 29, 2023 ALKS Restricted Stock Unit Award Ordinary Shares (5,985) — — 5,985 Acquired
June 29, 2023 ALKS Non Qualified Stock Option (Right to Buy) Ordinary Shares (12,732) $31.33 June 29, 2033 12,732 Acquired
June 8, 2023 ALKS Restricted Stock Unit Award Ordinary Shares (3,236) — — 3,236 Disposed
June 8, 2023 ALKS Restricted Stock Unit Award Ordinary Shares (373) — — 373 Disposed
July 7, 2022 ALKS Non Qualified Stock Option (Right to Buy) Ordinary Shares (11,554) $31.48 July 7, 2032 11,554 Acquired
July 7, 2022 ALKS Restricted Stock Unit Award Ordinary Shares (5,957) — — 5,957 Acquired
June 8, 2022 ALKS Non Qualified Stock Option (Right to Buy) Ordinary Shares (17,773) $28.97 June 8, 2032 17,773 Acquired
June 8, 2022 ALKS Restricted Stock Unit Award Ordinary Shares (9,709) — — 9,709 Acquired
June 8, 2022 ALKS Non Qualified Stock Option (Right to Buy) Ordinary Shares (714) $28.97 June 8, 2032 714 Acquired
June 8, 2022 ALKS Restricted Stock Unit Award Ordinary Shares (373) — — 373 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 16 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
April 17, 2026 WVE Ordinary Shares 45,625 Direct
April 17, 2026 WVE Share Option (Right to Buy)→ Ordinary Shares (300,000) 300,000 Direct
April 17, 2026 WVE Share Option (Right to Buy)→ Ordinary Shares (273,750) 273,750 Direct
Dec. 30, 2020 CYCN Common Stock 17,009 Direct
Dec. 30, 2020 CYCN Common Stock 28,356 Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock — Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock — Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock — Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock — Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock — Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock — Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock (23,437) 23,437 Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock (51,563) 51,563 Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock (75,000) 75,000 Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock (1,562) 1,562 Direct
Dec. 30, 2020 CYCN Employee Stock Option (Right to Buy)→ Common Stock (73,438) 73,438 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CYCN

M.D., Ph.D,(4)Chief Medical Officer
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2020 $456,125 — — $144,495 $158,328 — $8,132 $767,080

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.